The effect of morphine on formalin‐evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats
Open Access
- 1 March 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (5) , 1069-1075
- https://doi.org/10.1111/j.1476-5381.1995.tb13315.x
Abstract
1 In the present study, the object was to examine the effects of morphine on spinal release in vivo of excitatory amino acids (EAA), prostaglandin E2 (PGE2), and a marker for nitric oxide (NO) synthesis, citrulline (Cit), evoked by a protracted noxious stimulus produced by the injection of formalin into the paw. Spinal release was monitored in conscious rats using a microdialysis probe implanted into the subarachnoid space with the active site placed at the level of the lumbar enlargement. In split dialysate samples, EAAs were measured by high performance liquid chromatography (h.p.l.c.) and PGE2 was determined by radioimmunoassay. 2 Resting concentrations in nmol ml−1 for the amino acids (mean ± s.e.mean, n = 21) were: 4.8 ± 0.4 for glutamate (Glu), 0.8 ± 0.1 for aspartate (Asp), 8.8 ± 0.8 for taurine (Tau), 24 ± 3 for glycine (Gly), 19 ± 3 for serine (Ser), 5.2 ± 0.8 for asparagine (Asn), 64 ± 4 for glutamine (Gln) and 5.2 ± 0.4 for Cit. Mean basal release for PGE2 was 12 ± 1 pmol ml−1. 3 Subcutaneous (s.c.) injection of 5% formalin evoked a biphasic flinching behaviour (phase 1: 0–9 min and phase 2: 10–60 min) of the injected paw. Corresponding to phase 1 behaviour, there was a significant increase (50–100%) in spinal levels of Glu, Asp, Tau, Gly, Cit and PGE2, but not Ser, Asn and Gln. A significant (P2. However, Glu and Asp levels were increased by approximately 45%. 4 Injection of morphine sulphate (3 mg kg−1, s.c.) had no effect on resting release, but produced a significant suppression of the formalin-evoked behaviour and release of Glu, Asp, Tau, Gly, Cit and PGE2. The effect of morphine was reversed by pretreatment with 1 mg kg−1 naloxone. Naloxone by itself did not change the release or behaviour of the formalin test. 5 This study demonstrates that both spinal EAA and PGE2 release patterns correlate with behavioural nociceptive responses in the formalin test and that morphine suppresses the formalin-evoked behaviours and spinal release. The reversal by naloxone of the morphine effect indicates mediation via an opioid receptor.Keywords
This publication has 38 references indexed in Scilit:
- Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in ratsPain, 1993
- Comparison of the Antinociceptive Effects of Pre- and Posttreatment with Intrathecal Morphine and MK801, an NMDA Antagonist, on the Formalin Test in the RatAnesthesiology, 1992
- Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the ratNeuropharmacology, 1992
- Substance P‐Induced Release of Prostaglandins from Astrocytes: Regional Specialisation and Correlation with Phosphoinositol MetabolismJournal of Neurochemistry, 1991
- Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cordPain, 1990
- The rat paw formalin test: comparison of noxious agentsPain, 1990
- Microdialysis—Theory and applicationProgress in Neurobiology, 1990
- Morphine and norepinephrine but not 5-hydroxytryptamine and γ-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slicesBrain Research, 1986
- Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature, 1980
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977